<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2155">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05133102</url>
  </required_header>
  <id_info>
    <org_study_id>AAAS2622</org_study_id>
    <nct_id>NCT05133102</nct_id>
  </id_info>
  <brief_title>Longitudinal Oral Microbiome Sampling for BE</brief_title>
  <official_title>Repeated Sampling of the Oral Microbiome to Improve Detection of Barrett's Esophagus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a longitudinal cohort study to assess the impact of repeated sampling of an oral&#xD;
      microbiome signature for Barrett's esophagus (BE). Potential participants will be identified&#xD;
      through chart review of patients who have had an endoscopy in the past three years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Saliva collection is non-invasive and can be performed in clinical and non-clinical settings.&#xD;
      As such, saliva testing is a highly attractive method for diagnosing and/or monitoring&#xD;
      disease. The investigators previously showed that the bacterial make-up (&quot;microbiome&quot;) of&#xD;
      saliva is highly distinct in patients with and without Barrett's esophagus (BE), a precursor&#xD;
      to esophageal cancer that normally can only be diagnosed by undergoing an upper endoscopy.&#xD;
      While the microbiome of saliva is felt to be relatively stable over time, it is unclear&#xD;
      whether a microbiome signature for Barrett's esophagus is reproducible within individuals.&#xD;
      Also, repeated testing of saliva may improve the ability to diagnose Barrett's esophagus.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Performance characteristics of a microbiome-based classifier with repeated sampling</measure>
    <time_frame>2 months</time_frame>
    <description>Using a classifier developed from 16S rRNA gene sequencing data, we will calculate the area under the receiver operating curve (AUROC) and associated 95% confidence interval for a classifier with three repeated measures per subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-class correlation coefficients (ICC) by BE status</measure>
    <time_frame>2 months</time_frame>
    <description>This will be measured to determine the degree of consistency of a microbiome-based classifier for each individual's salivary microbiome assessments (three total per subject).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">275</enrollment>
  <condition>Barrett Esophagus</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients who have undergone an endoscopy within the last three years and have never been diagnosed with Barrett's esophagus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Barrett's Esophagus</arm_group_label>
    <description>Patients who have undergone an endoscopy within the last three years and have histologically confirmed Barrett's esophagus. BE segment must be M&gt;1cm, and has not be treated with endoscopic eradication therapy (focal mucosal resection without subsequent eradication therapy is allowed).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sample collection</intervention_name>
    <description>Collection of saliva sample</description>
    <arm_group_label>Barrett's Esophagus</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Enrollment will continue until a total of 250 subjects complete all three saliva specimen&#xD;
        collections:&#xD;
&#xD;
          -  50 BE patients&#xD;
&#xD;
          -  200 controls&#xD;
&#xD;
        The investigators anticipate that approximately 10% of subjects will not complete all three&#xD;
        specimen collections and will be excluded from the primary outcome analyses. Thus, the&#xD;
        investigators expect to enroll ~275 subjects to have 250 with three saliva specimen&#xD;
        collections. There is no cap on enrollment per study site. The anticipated duration of&#xD;
        enrollment is 2 years (24 months).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for an upper endoscopy or had upper endoscopy within past three years&#xD;
&#xD;
          -  Eighteen years of age or older&#xD;
&#xD;
          -  Capable of producing a saliva sample&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
          -  For BE patients only: Endoscopic evidence of Barrett's esophagus (at least 1 cm&#xD;
             maximal BE length; i.e. Prague classification: any C, Mâ‰¥1), and intestinal metaplasia&#xD;
             present on esophageal biopsies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of head and neck cancer or esophageal squamous cell or gastric cancer&#xD;
&#xD;
          -  History of esophageal or gastric surgery&#xD;
&#xD;
          -  Scheduled to undergo colonoscopy on the day of initial saliva collection&#xD;
&#xD;
          -  Scheduled only for Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopy&#xD;
             ultrasound (EUS) without accompanying standard upper endoscopy on the day of initial&#xD;
             saliva collection&#xD;
&#xD;
          -  For BE patients only: History of prior endoscopic therapy for BE except a history of&#xD;
             prior Endoscopic mucosal resection (EMR) of focal lesions without subsequent ablative&#xD;
             therapy is permitted&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian Abrams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julian Abrams, MD</last_name>
    <phone>212-305-1909</phone>
    <email>ja660@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katharine Boyce, RN</last_name>
    <email>kb3217@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel H. Rubenstein, MD</last_name>
      <email>jhr@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amy Liu</last_name>
      <email>Liuyalie@med.umich.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julian Abrams, MD</last_name>
      <phone>212-305-1909</phone>
      <email>ja660@cumc.columbia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Julian A Abrams, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Saliva</keyword>
  <keyword>Sampling</keyword>
  <keyword>Oral Microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barrett Esophagus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

